FT Online edition (download the PDF version). PDF version of the Financial Times Article Jan 27th 2017
Download the PDF version of the article (in Danish) here.
OSSIANIX USES SHARK-DERIVED ANTIBODIES TO CROSS THE BBB NeuroInsights 1st February 2016 Ossianix was founded in 2012 by Frank Walsh, Corey Goodman and Lynn Rutkowski, distinguished neuroscientists with extensive academic careers and senior level experience in the pharmaceutical industry. NeuroInsights caught up with Ossianix’s CEO Frank Walsh to discuss their innovative approach to crossing the blood-brain barrier. During Walsh’s tenure at Wyeth, it became apparent to him that biological approaches…
Read full article: Biocentury 28 Sept 2014